​2024 Joint Chairmen's ​Reports

• ​​Quarterly R​eports on Medicaid and MCHP Enrollment and Applications 
• ​​​Quarter 1​​
  
• ​Quarter 2​​

2024 Legislative Reports

• Report Required by Health - G​eneral §15-103.8 and HB 684 - Ch. 691 of the Acts of 2022- IMD Services for Medicaid Participants with Serious Mental Illness and Substance Use Disorder​
• Report Required by Health-General Article § 8-1102(c) – 2024 Report on Analysis of 

  Medications to Treat Opioid Use Disorder – Preferred and Non-Preferred Medications

   

  (MSAR# 14171)​
• ​Report Required By Health – General Article § 15–114.1 and Chapter 668 of the Acts of 2022: Maryland Medical Assistance Program – Emergency Service Transporters – Reimbursement (MSAR # 14117)​
  
• Health General Article § 19-310.1(f) - FY 2024 Nursing Home Health Quality Assessment Implementation Annual Report (MSAR #10382)​​
• Report required by Health General Article § 13-2504(b): 2024 Annual Oral Health
• Legislative Report (MSAR #10381)​
  
  
  

​2023 Joint Chairmen's ​Reports

• Report on Employed Individuals with Disabilities (EID) Program Eligibility Requirements and Expenditures​​
  
• Implementation of a Reimbursement Rate Increase for Dental Services Covered by Medicaid
• Report on Current Medicaid Rate Structures & Rate-Setting Studies​
• Report on Remote Services Model for Ad​ult Medical Day Care Clients and Centers​
• Report on Community First Choice and Community Options Waiver Financial and Registry Data (August)
  
• Report on Community First Choice and ​​Community Options Waiver Financial and Registry Data​ (December)​
  
• Report on a Closed-Loop Referral Platform for Medicaid and Maryland Children’s Health Program Participants’ Health-Related Social Needs
• Report on Health Care and Dental Coverage for Undocumented Immigrants​
• Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 2
• ​​Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 3
  
• Attachment 1: Medicaid Data Dashboard
  
• Attachment 2: JCR Requested Metrics
  
• Attachment 3: Unwinding Data FAQs
• Attachment 4: Medicaid Check-In Presentation​
• Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 4​
• ​Attachment 1: Medicaid Data Dashboard
  
• Attachment 2: JCR Requested Metrics
  
• Attachment 3: Unwinding Data FAQ 
• Attachment 4: Medicaid Check-In Presentation
  
• Attachment 5: Medicaid Redetermination Comprehensive Communications Summary, September 2023​​
  
• Reports on​ Home- and Community-Based Options (Community Options) Waiver Care Plan Backlog:
  
• ​July 2023 Report
• August 2023 Report
• September 2023 Report
• October 2023 Report
• November 2023 Report
• December 2023 Report 
  
• January 2024 Report
• February 2024 Report 
• March 2024 Report
• April 2024 Report​ 
• May 2024 Report​​
• June 2024 Report​
• SPDAP annual report - 2023
  
• SPDAP annual report - 2024​
  
• Report on CFC Program and Community Options Waiver Financial and Registry Data​
• Report on Recoupment, Forgiveness and ASO Transition
• Implementation of Recommendations from Financial Compliance Report​​
  
  

2023 Legislative Reports

• FY 2023 Nursing Home Health Quality Assessment Implementation Annual Report (MSAR #10382) -Health General Article § 19-310.1(f)
• Report on Personal Care Aides Providing Home Care at Residential Services Agencies -HB544/SB600, Ch. 673/674 (2022) (MSAR # 14327) 
• Report on Managed Care Organizations and Prescription Drug Claims - HB 382, Ch. 217 (2023​)​​​
• 2023 Annual Report on the Maryland Medical Assistance Program and the Maryland Children’s Health Program –Provider ​Reimbursement Rates (MSAR #7893)​​
• 2023 Annual Oral Health Legislative Report, Health-General Article, Section 13-
   
  2504(b) and HB 70 (Chapter 656 of the Acts of 2009) (MSAR #10381)​
  
  
  
• Report required by Health-General Article § 15-1103 and Ch. 378/379 of the Acts of 2023 - 2023 Annual Report on En​rollment in the 1915(i) Model and Child and Adolescent Case Management Services (MSAR ​#14577)​
• Report Required by Health-General Article § 8-1102(c) and Ch. 82 and Ch. 83 of the Acts of 2022 – 2023 Report on Initial Analysis of Medications to Treat Opioid Use Disorder – Preferred and Non-Preferred Medications (MSAR# 14171)